US Patent 7879813 Interfering RNA delivery system and uses thereof
Patent 7879813 was granted and assigned to Alcon on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+308 characters)
Article
Patent abstract
The invention provides a delivery system comprising a cell penetrating peptide, a polyarginine peptide, and an interfering RNA molecule. The system can be used for delivering interfering RNA molecules into a cell in vivo or in vitro. Therapeutic uses for the delivery system are also provided.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Jon E. Chatterton0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07879813 Interfering RNA delivery system and uses thereof US Patent 7879813 Interfering RNA delivery system and uses thereof
Infobox
Patent Number
078798130
Patent Number
78798130
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078798130
Date of Patent
February 1, 2011
0Patent Application Number
123382520
Date Filed
December 18, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07879813 Interfering RNA delivery system and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07879813
Date of patent
February 1, 2011
Patent application number
12338252
Date Filed
December 18, 2008
Patent primary examiner
Find more entities like US Patent 7879813 Interfering RNA delivery system and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.